dementia

Wendy Williams, the renowned talk show host, has been diagnosed with dementia, the same type that actor Bruce Willis is battling, as per a statement issued on her behalf, according to a report. What Happened: Williams has been diagnosed with primary progressive aphasia and frontotemporal dementia....

A rematch of the 2020 presidential election could be what voters will head to the polls to decide in the November 2024 presidential election. Donald Trump and Joe Biden continue to lead their respective parties in the race and could give voters little choice but to select a candidate who could...

Former First Lady Rosalynn Carter, a longtime advocate for expanded access to mental health care, has been diagnosed with dementia, the Carter Center announced Tuesday. “She continues to live happily at home with her husband, enjoying spring in Plains and visits with loved ones,”...

In a recent study published in Frontiers in Medicine, researchers showed that "almost 90% of patients with dementia suffer from some type of neurobehavioral symptom, and there are no approved medications to address these symptoms." Neuropsychiatric symptoms (NPS) occur in up to...

This article was originally published on Cannabis.net and appears here with permission. There are over 5.8 million persons in the United States living with Alzheimer's disease, and of this number, 80% are above 75 years and older. Of the 50 million persons with dementia worldwide, about 70%...

Alector Inc (NASDAQ: ALEC) detailed early data from its lead drug, AL001, INFRONT-2 Phase trial at the Alzheimer's Association International Conference (AAIC 2021) Patients with one type of frontotemporal dementia decline because they're missing one copy of an immune-...

Anavex Life Sciences Corp (NASDAQ: AVXL) has reported that SIGMAR1 mRNA expression correlates positively with responses in efficacy endpoints in the Phase 2 trial of ANAVEX 2-73 (blarcamesine) in patients with Parkinson's disease dementia. ANAVEX 2-73 activates the sigma-1...

Voyager Therapeutics Inc (NASDAQ: VYGR) has announced new preclinical data characterizing the durable expression and activity of a vectorized anti-tau antibody. The results will be presented at the American Society of Gene and Cell Therapy. Data demonstrate durable expression...

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares came under pressure Monday after the Food and Drug Administration (FDA) rejected its regulatory application seeking label expansion for its dementia drug. The Acadia Analysts: Goldman Sachs analyst Salveen Richter downgraded Acadia shares...

Aptinyx Inc (NASDAQ: APTX) has restarted patient screening in a Phase 2 study evaluating NYX-458 in patients with mild cognitive impairment and mild dementia associated with Parkinson's disease and dementia with Lewy bodies. Aptinyx will release the data from this...

The FDA has issued a Complete Response Letter (CRL) to Acadia Pharmaceuticals Inc (NASDAQ: ACAD) regarding its supplemental marketing application (for Nuplazid (pimavanserin) for the treatment of hallucinations and delusions associated with dementia-related psychosis (DRP...

Axovant Sciences Ltd (NASDAQ: AXON)'s announcement this week that its lead drug candidate intepirdine failed in a late-stage trial comes after the stock lost 90 percent of its value over the past three months following a negative announcement on an Alzheimer's trial.  The Analyst...